This guideline includes statements and recommendations based on available, high-level evidence about the use of bisphosphonates in women with advanced breast cancer. The guideline provides health professionals with information designed to help them make management recommendations for improved patient outcomes. The guideline, funded by the National Breast Cancer Foundation, has been endorsed by the Medical Oncology Group of Australia, and the Faculty of Radiation Oncology at the Royal Australian and New Zealand College of Radiologists.
| Filename | Unknown |
| Filesize | Link |
| Filetype | au/guidelines/bisphosphonates_advanced/ (Mime Type: link) |
| Created On: | 22/07/2011 12:21 |
| Last updated on | 22/07/2011 12:22 |